In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Essential oils can relieve symptoms of chronic obstructive pulmonary disease (COPD) or aid other therapies. However, they cannot be used as a substitute...